首页|CT灌注成像、CT增强检查在脑胶质瘤手术患者中的应用价值分析

CT灌注成像、CT增强检查在脑胶质瘤手术患者中的应用价值分析

扫码查看
目的 探究CT灌注成像、CT增强检查在脑胶质瘤手术患者中的应用价值分析。方法 回顾性分析 2021 年 1月至 2022 年 12 月期间,新乡市第一人民医院收治的脑胶质瘤手术患者共计 98 例,根据检查方法的不同将上述研究对象划分为CT灌注组(n=52)以及CT增强组(n=46);以手术切除后的病理检测报告为金标准,分析上述两种检测方案应用于脑胶质瘤手术患者的应用价值。结果 在CT灌注组确诊的 24 例低级别患者与 28 例高级别患者中,低级别组与高级别组患者的脑血流量(CBF)以及脑血容量(CBV)水平在健侧区比较,差异无统计学意义(P>0。05);而在病灶区,高级别组的CBF与CBV水平显著高于低级别组,差异有统计学意义(P<0。05)。在CT增强组确诊的 21 例低级别与25例高级别患者中,低级别组与高级别组患者的CT增强值在健侧区比较,差异无统计学意义(P>0。05);而在病灶区,高级别组的CT增强值显著高于低级别组,差异有统计学意义(P<0。05)。CT灌注应用于脑胶质瘤患者诊断的灵敏度为 96%、特异度为 100%、准确度为 96。15%、阳性预测值为 1。00、阴性预测值为 0。5、Kappa值为 0。649;CT增强应用于脑胶质瘤患者诊断的灵敏度为52。50%、特异度为100%、准确度为58。70%、阳性预测值为1。00、阴性预测值为0。24;Kappa值 0。224。CT灌注组术的诊断准确率高于CT增强组。结论 CT灌注成像有助于提高术前分级诊断的准确性,然而不同级别组的CT灌注与CT增强参数均存在统计学差异,对于脑胶质瘤恶性病变风险评估均具有一定的参考价值。
Application Value of CT Perfusion Imaging and CT Enhancement Examination in Patients Undergoing Brain glioma Surgery
Objective To explore the application value of CT perfusion imaging and CT enhancement examination in patients undergoing brain glioma surgery.Methods A total of 98 patients undergoing brain glioma surgery the First People's Hospital of Xinxiang City were retrospectively analyzed between January 2021 and December 2022.According to different examination methods,they were divided into CT perfusion group(n=52)and CT enhancement group(n=46).Taking the pathological examination report after surgical resection as the gold standard,application value of the above two detection methods in patients undergoing brain glioma surgery was analyzed.Results Among the 24 low-grade patients diagnosed with CT perfusion and 28 high-grade patients diagnosed with CT perfusion,there was no significant difference in cerebral blood flow(CBF)and cerebral blood volume(CBV)on healthy side between low-grade group and high-grade group(P>0.05),but CBF and CBV of lesion area in high-grade group were significantly higher than those in low-grade group,and the difference was statistically significant(P<0.05).Among the 21 low-grade patients and 25 high-grade patients in CT enhancement group,there was no significant difference in CT enhancement value on healthy side between low-grade group and high-grade group(P>0.05),but CT enhancement value of lesion area in high-grade group was significantly greater than that in low-grade group,and the difference was statistically significant(P<0.05).The sensitivity,specificity and accuracy of CT perfusion were 96%,100%,96.15%,1.00 positive predictive value,0.5 negative predictive value and 0.649 Kappa value in the diagnosis of glioma patients.The sensitivity,specificity and accuracy of enhanced CT were 52.50%,100%,58.70%,1.00 positive predictive value and 0.24 negative predictive value in the diagnosis of glioma.The Kappa value was 0.224.The diagnostic accuracy of CT perfusion group was higher than that of CT enhancement group.Conclusion CT perfusion imaging is beneficial to improve diagnostic accuracy of preoperative grading.However,there are statistical differences between different levels of CT perfusion and CT enhancement parameters,which have certain reference value for the risk assessment of malignant glioma lesions.

brain gliomaCT perfusion imagingCT enhancement examinationapplication value

张小艳、王梦、王举华、张岩、李振强

展开 >

新乡市第一人民医院 CT室,河南 新乡 453000

新乡市第一人民医院 内科,河南 新乡 453000

脑胶质瘤 CT灌注成像 CT增强检查 应用价值

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(1)
  • 20